Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

629.35 +12.15 (+1.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday. 
Via Chartmill
News headline image
Top S&P500 movers in Monday's session ↗
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Stocks Trim Losses On Mexico Tariff Delay, Gold Extends Records, Tesla Sinks 6%: What's Driving Markets Monday? ↗
Wall Street bounced back after President Donald Trump and Mexican President Claudia Sheinbaum agreed to a one-month suspension of tariffs following Mexico's pledge to bolster its military presence at... 
Via Benzinga
Topics Government World Trade
News headline image
Assessing IDEXX Laboratories: Insights From 4 Financial Analysts ↗
 
Via Benzinga
News headline image
(IDXX) - Analyzing IDEXX Laboratories's Short Interest ↗
 
Via Benzinga
News headline image
(IDXX) - Analyzing IDEXX Laboratories's Short Interest ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 1, 2025 ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
A Look Into IDEXX Laboratories Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About IDEXX Laboratories? ↗
 
Via Benzinga
News headline image
Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 ↗
Via The Motley Fool
Topics Stocks
News headline image
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks ↗
Every stock tells a story; it takes humans to find the meaning in it. 
Via The Motley Fool
News headline image
Why Idexx Labs Stock Rocketed Higher This Week ↗
Via The Motley Fool
News headline image
A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts ↗
 
Via Benzinga
News headline image
Decoding 5 Analyst Evaluations For IDEXX Laboratories ↗
 
Via Benzinga
News headline image
IDEXX Laboratories Posts Upbeat Results, Joins Stratasys, Saia And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High ↗
The company sells diagnostic equipment for veterinarians. Fourth-quarter metrics grew and beat expectations. 
Via Investor's Business Daily
News headline image
Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday? ↗
Idexx Laboratories posted strong Q4 earnings, beating estimates with 10% EPS growth. 2025 guidance reflects up to 7% revenue growth and $1.5 billion in buybacks. 
Via Benzinga
News headline image
Idexx: Q4 EPS, Revenue Beat Forecast ↗
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments. 
Via The Motley Fool
News headline image
Earnings Scheduled For February 3, 2025 ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today ↗
 
Via Benzinga
News headline image
These S&P500 stocks have an unusual volume in today's session ↗
Let's have a look at what is happening on the US markets on Monday. Below you can find the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass ↗
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI). 
Via Benzinga
Topics Artificial Intelligence
News headline image
Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A 'Great Stock' ↗
 
Via Benzinga
News headline image
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More ↗
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
News headline image
What Analysts Are Saying About IDEXX Laboratories Stock ↗
 
Via Benzinga
News headline image
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025 ↗
Via The Motley Fool
Topics Stocks
News headline image
Is It Time to Buy October's Worst-Performing Nasdaq Stocks? ↗
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today. 
Via The Motley Fool
News headline image
A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback ↗
Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today. 
Via The Motley Fool
Topics Stocks
News headline image
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth ↗
Idexx Laboratories posted a Q3 EPS of $2.79, beating estimates, though revenue of $975.54 million fell short. Veterinary trends and guidance update key 2024 outlook. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.